Logo image
AGCS – The AudioGene Confidence Score: an interpretable post-hoc confidence metric for machine learning-based gene prediction in autosomal dominant non-syndromic hearing loss
Thesis   Open access

AGCS – The AudioGene Confidence Score: an interpretable post-hoc confidence metric for machine learning-based gene prediction in autosomal dominant non-syndromic hearing loss

Nathan Schaefer
University of Iowa
Master of Science (MS), University of Iowa
Spring 2026
DOI: 10.25820/etd.008386
pdf
Nathan_Schaefer_AGCS_Thesis_Final2.96 MBDownloadView
Open Access

Abstract

Autosomal dominant non-syndromic hearing loss (ADNSHL) presents a significant genetic diagnosis challenge due to the phenotypic heterogeneity of the condition. Mutations in dozens of distinct genes can produce nearly indistinguishable audiometric profiles, making gene- level prediction from hearing test data alone inherently difficult. AudioGene is a clinical decision support tool that applies machine learning to audiometric data to produce a ranked list of candidate causative genes. Its two underlying models, AudioGene V4 (AG4) and AudioGene V9.1 (AG9.1), cover 23 ADNSHL gene classes, achieving top 3 accuracies of 70.9% and 77.8% respectively on the training dataset. An inherent class imbalance in the training dataset has imposed a practical performance ceiling on both models. Prior work introduced the AudioGene Translational Dashboard (AGTD) to improve prediction interpretability; however, the AGTD visualizes the training dataset rather than the model's internal decision processes and introduces a learning curve for less experienced users. As part of this work, AG9.1 was refined into AG9.2, a simpler ensemble architecture with improved performance. This thesis introduces the AudioGene Confidence Score (AGCS), a post-hoc confidence scoring system for both AG4 and AG9.2 that stratifies predictions into five clinically meaningful tiers: Extremely Low, Low, Medium, High, and Extremely High. As a secondary contribution, the training dataset was resampled to reflect real-world gene prevalence statistics from the University of Iowa MORL lab, and thresholds were validated through cross-validation on this resampled dataset. High and Extremely High tier predictions correspond to top 3 accuracies exceeding 93% and 98% for AG9.2, and exceeding 91% and 95% for AG4. Clinical case studies demonstrate that the AGCS provides meaningful diagnostic guidance across a range of prediction scenarios, representing a substantive step toward more interpretable and actionable AudioGene predictions.

Details

Metrics

1 Record Views
Logo image